Home » Tenders » Europe » Poland » "Delivery of Investigational Medicinal Products for a Clinical Trial Entitled... Tender

"Delivery of Investigational Medicinal Products for a Clinical Trial Entitled "A... Tender

Download Documents

STEFAN CARDINAL WYSZYŃSKI NATIONAL INSTITUTE OF CARDIOLOGY - NATIONAL RESEARCH INSTITUTE has floated a tender for "Delivery of Investigational Medicinal Products for a Clinical Trial Entitled "A Randomized, Open-Label Clinical Trial Assessing the Anti-Atherosclerotic Effectiveness of Selected Antidiabetic Drugs in Patients With.... The project location is Poland and the tender is closing on 29 Apr 2024. The tender notice number is 176317-2024, while the TOT Ref Number is 99266090. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Poland

Summary : "Delivery of Investigational Medicinal Products for a Clinical Trial Entitled "A Randomized, Open-Label Clinical Trial Assessing the Anti-Atherosclerotic Effectiveness of Selected Antidiabetic Drugs in Patients With...

Deadline : 29 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99266090

Document Ref. No. : 176317-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : STEFAN CARDINAL WYSZYŃSKI NATIONAL INSTITUTE OF CARDIOLOGY - NATIONAL RESEARCH INSTITUTE
Address: ul. Alpejska 42
Town: Warszawa
NUTS-Code: PL911
Postal Code: 04-628
Attn: Public Procurement Department
Phone: 48 228124570
Poland
Email :zamowieniapubliczne@ikard.pl
URL :https://ikard.ezamawiajacy.pl

Tender Details

"Delivery of investigational medicinal products for a clinical trial entitled "Randomized, open clinical trial assessing the anti-atherosclerotic effectiveness of selected antidiabetic drugs in patients with...

" Delivery of investigational medicinal products for the clinical trial entitled "Randomized clinical trialan open study assessing the antiatherosclerotic effectiveness of selected antidiabetic drugs in patients with coronary artery disease and prediabetes. CASCADES trial."

1.The subject of the order is: delivery of investigational medicinal products for a clinical trial entitled "Randomized clinical trial, openarte, assessing the antiatherosclerotic effectiveness of selected antidiabetic drugs in patients with coronary artery disease and prediabetes. CASCADES trial" in accordance with the principles of GCP and GDP financed under the Medical Research Agency competition ABM/2023/1 regarding the financing of non-commercial clinical trialscommunicative.

Part No. 1 - Rybelsus 3 mg, 7mg, 14 mg

Part No. 2 - Formetic 500 mg

Part No. 3 - Forxiga 10 mg

Doc Title: "Supply of investigational medicinal products for a clinical trial entitled "A randomized, open-label clinical trial assessing the anti-atherosclerotic effectiveness of selected anti-diabetic drugsch in patients with coronary heart disease and prediabetes. CASCADES trial.""

Contract Type: supplies
Document Type: Contract Notice
Reference Number: ZP.013.2024
Contract Type: supplies
Authority Type: body-pl
Doc Title: "Supply of investigational medicinal products for a clinical trial entitled "A randomized, open clinical trial assessing the anti-atherosclerotic effectiveness of selected anti-diabetic drugslife in patients with coronary heart disease and prediabetes. CASCADES trial.""
Dispatch Date: 2024-03-22
Publish Date: 2024-03-25
Submission Date: 2024-04-29